Gabapentin Capsule
Product Images NDC 60760-864

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60760-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 01)

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 02)

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 03)

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 04)

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 05)

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 05)
Not available.*
FDA Label Image

864-90 (Gabapentin 60760 864 90)

864-90 (Gabapentin 60760 864 90)
This text provides information about Gabapentin capsules, each containing 400mg of Gabapentin. The capsules are manufactured by Gravii Pharmaceuticals in Telangana, India. The prescription number for these capsules is RX#200000002. The lot numbers vary among EFO068F, EFO0GSF, EFO0SBF, and EFO0BHF, with an expiration date of 0426. It is recommended to store these capsules at a controlled room temperature of 15°-30°C (59°-86°F) and use them as directed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.